Omaha — Omaha, Nebraska

Omaha is a clinical research site located in Omaha, Nebraska, United States 68198-4031.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Omaha has participated in 8 clinical trials with 2 currently active.

Therapeutic areas: Clostridium Difficile Infection (CDI), Endometriosis Related Pain, Pulmonary Hypertension.

Sponsors: Rebiotix Inc., Myovant Sciences GmbH, Tectonic Therapeutic.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Omaha?

Omaha has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Omaha conducted?

Omaha has 8 clinical trials on record, with 2 currently active. Their work covers Clostridium Difficile Infection (CDI), Endometriosis Related Pain, Pulmonary Hypertension.

Is Omaha accredited by Crixeo Health?

Yes — Omaha holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Omaha?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.